Neumentum, Inc. logo — company profile

Neumentum, Inc.

Founded 2017 United States Morristown, United States 6 employees Series Unknown Biotechnology, Health Care +3

General Information

Company Name Neumentum, Inc.
Founded Year 2017
Location United States Morristown, United States +1
Employees 6
Industries Biotechnology, Health Care, Health and Wellness +2
Funding Stage Series Unknown
Social

Get notified when Neumentum, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Neumentum, Inc.

Neumentum is dedicated to becoming a leading non-opioid analgesic and neurology specialty pharmaceutical company with 4 novel non-opioid products in development to treat pain, both in the U.S. and around the world. The Company aims to address shortfalls of current pain management treatments by developing and commercializing effective and safe, non-opioid options without the risks of abuse, misuse, and diversion seen with opioids, or the opioid-induced side effects, including potentially life-threatening respiratory depression. Neumentum has two lead product candidates being developed to directly help address the opioid crisis. NTM-001, currently in Phase 3, is an IV formulation of Toradol (ketorolac) with Phase I results showing that it may provide consistent, steady blood plasma levels of ketorolac over 24 hours and durable analgesic effect. NTM-001 has the potential to be the first-ever NSAID approved for continuous infusion. NTM-006, a Phase 2 novel oral analgesic with a target indication for acute and chronic pain that has demonstrated meaningful analgesia in a Phase 2a Proof of Concept study, was licensed from Janssen Pharmaceuticals NV and McNeil Consumer Pharmaceuticals Co., both part of the Johnson & Johnson Family of Companies. Neumentum is led by an executive team of biotech and pharmaceutical experts who have extensive experience in pain and neurology, from drug development through commercialization. For more information, visit www.Neumentum.com.

No funding data available for Neumentum, Inc. yet.

Get notified when Neumentum, Inc. raises funding

Neumentum, Inc. Alternatives & Competitors

Neumentum, Inc. vs

Maxona pharmaceuticals is committed to leveraging an ex-u

Unknown
9 employees
Biotechnology, Health Care
Neumentum, Inc. vs

Semnur Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the clinical and comme...

Series Unknown
2 employees
Biotechnology, Pharmaceutical
Neumentum, Inc. vs
iN Therapeutics
iN Therapeutics Korea South

의학 및 약학 연구개발업

Series B
8 employees
Biotechnology, Health and Wellness

FAQ About Neumentum, Inc.

Neumentum is dedicated to becoming a leading non-opioid analgesic and neurology specialty pharmaceutical company with 4 novel non-opioid products in development to treat pain, both in the U.S. and around the world. The Company aims to address shortfalls of current pain management treatments by devel...
Neumentum, Inc. was founded in 2017.
Neumentum, Inc. is headquartered in Morristown, United States.
Neumentum, Inc. operates in the following industries: Biotechnology, Health Care, Health and Wellness, Life Sciences, Pharmaceutical.
Neumentum, Inc. has approximately 6 employees.
Top alternatives and competitors to Neumentum, Inc. include MAXONA Pharmaceuticals, Semnur Pharmaceuticals, Inc., iN Therapeutics, Akelos Inc, Cavion. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Neumentum, Inc. and MAXONA Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Neumentum, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy